As the Indian stock market gears up for the annual Diwali Muhurat Trading session, let’s take a look at how the Sensex and Nifty have performed over the years and what investors can expect from this auspicious trading session.
Get the latest updates on Muhurat Trading 2025, including timings, top stocks to buy, and investment strategies for Samvat 2082. Learn how to make the most of this auspicious trading session.
Morgan Stanley has raised the target price for Bank of India after the lender reported its September quarter earnings, highlighting improving asset quality metrics, but flags concerns over future earnings.
Get the latest Muhurat Trading stock picks and top brokerage recommendations for Indian investors, including Laurus Labs, Can Fin Homes, and Bank of India.
Kotak Institutional Equities upgrades Blue Jet Healthcare to ‘buy’ rating and increases target price for Piramal Pharma, citing opportunities in the global market for high-cholesterol drugs.
Infosys emerges as the top-gaining stock in the Nifty 50 on Muhurat day trade, driven by a positive movement in the IT space. What’s behind the rally and how can investors make the most of it?
Catch the latest updates from the Indian stock markets, including Muhurat trading highlights, Nifty levels, Q2 results, and major corporate actions affecting investor sentiment.
The Indian stock markets witnessed a mixed trend during the Diwali Muhurat trading session, with Nifty Realty emerging as the top sectoral loser. Get the latest updates on Nifty levels, sectoral performance, and major corporate actions affecting investor sentiment.
Laurus Labs share price rose as B&K Securities initiated coverage and projected an 18% upside potential for the stock price, driven by strong growth in its contract development and manufacturing organisation segment.
Can Fin Homes share price rose in the special Muhurat Trade session as Morgan Stanley maintained an Overweight rating and hiked target price following an upbeat second-quarter result.